glp-1 and bowel obstruction What are the symptoms of gastrointestinal paralysis GLP-1 Medicines And Gut Bacterial

6.6 When to Refer Referral to a clinician or dietitian may be appropriate when: Persistent GI intolerance limits intake Weight loss exceeds 20% body weight Multiple laboratory abnormalities are present Underlying malabsorptive or gastrointestinal disease exists Patient is elderly or medically complex GLP-1 therapy should not occur in isolation from nutritional oversight when risk factors are present

cloudiness, yellowing, or visible particles indicate chemical breakdown

Therefore, we recommend that companies start working on these no later than the beginning of 2026

empagliflozin for both analyses)

Combination therapy is typically considered for patients with inadequate glycemic control on GLP-1 monotherapy or when cost, adherence, or side effects favor adding an oral DPP-4 rather than increasing GLP-1 dose

The program is focused on medication access only